0001225208-20-012462.txt : 20201014 0001225208-20-012462.hdr.sgml : 20201014 20201014110139 ACCESSION NUMBER: 0001225208-20-012462 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201012 FILED AS OF DATE: 20201014 DATE AS OF CHANGE: 20201014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Ray G CENTRAL INDEX KEY: 0001416453 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00044 FILM NUMBER: 201238477 MAIL ADDRESS: STREET 1: 77 WEST WACKER DR. STREET 2: SUITE 4600 CITY: CHICAGO STATE: IL ZIP: 60601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Archer-Daniels-Midland Co CENTRAL INDEX KEY: 0000007084 STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070] IRS NUMBER: 410129150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 77 W. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60601 BUSINESS PHONE: 312-634-8233 MAIL ADDRESS: STREET 1: 77 W. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60601 FORMER COMPANY: FORMER CONFORMED NAME: ARCHER DANIELS MIDLAND CO DATE OF NAME CHANGE: 19920703 4 1 doc4.xml X0306 4 2020-10-12 0000007084 Archer-Daniels-Midland Co ADM 0001416453 Young Ray G 77 WEST WACKER DRIVE SUITE 4600 CHICAGO IL 60601 1 Chief Financial Officer Common Stock 2020-10-12 4 M 0 49020.0000 26.1700 A 448997.6288 D Common Stock 2020-10-12 4 S 0 49020.0000 50.0160 D 399977.6288 D Employee stock option (right to buy) 26.1700 2020-10-12 4 M 0 49020.0000 0.0000 D 2021-08-11 Common Stock 49020.0000 31357.0000 D Sale of shares pursuant to Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.02, inclusive. The reporting person undertakes to provide to ADM, any security holder of ADM, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Includes 4,369.628807 shares acquired pursuant to the Company's dividend reinvestment plan. Fully exercisable. Thuy Vo, Attorney-In-Fact 2020-10-13